Being a leading player in the area of drug discovery, Glenmark has three Research & Development facilities dedicated primarily to drug discovery. In addition, the company has an R&D facility for formulations development & Novel Drug Delivery Systems(NDDS).

The R&D centre at Navi Mumbai, India is focused on discovering New Chemical Entities(NCEs) and taking them till the stage of Clinical development; the R&D centre situated in Neuchatel, Switzerland is focused on New Biologic Entity(NBE) research and the third R&D centre situated in Oxford, United Kingdom is for molecules in clinical development both NCEs and NBEs. The fourth R&D centre at Sinnar, India is focused on developing Specialty/ Branded formulations for global markets.